CoChat

Resistance training prescription for muscle strength and hypertrophy in healthy adults: a systematic review and Bayesian network meta-analysis.

Open access

The DOI matches its Crossref record; 84 of the 86 references it cites were found in a registry or an index, and 2 are not checked yet.

Abstract

Objective: To determine how distinct combinations of resistance training prescription (RTx) variables (load, sets and frequency) affect muscle strength and hypertrophy. Data sources: MEDLINE, Embase, Emcare, SPORTDiscus, CINAHL, and Web of Science were searched until February 2022. Eligibility criteria: Randomised trials that included healthy adults, compared at least 2 predefined conditions (non-exercise control (CTRL) and 12 RTx, differentiated by load, sets and/or weekly frequency), and reported muscle strength and/or hypertrophy were included. Analyses: Systematic review and Bayesian network meta-analysis methodology was used to compare RTxs and CTRL. Surface under the cumulative ranking curve values were used to rank conditions. Confidence was assessed with threshold analysis. Results: The strength network included 178 studies (n=5097; women=45%). The hypertrophy network included 119 studies (n=3364; women=47%). All RTxs were superior to CTRL for muscle strength and hypertrophy. Higher-load (>80% of single repetition maximum) prescriptions maximised strength gains, and all prescriptions comparably promoted muscle hypertrophy. While the calculated effects of many prescriptions were similar, higher-load, multiset, thrice-weekly training (standardised mean difference (95% credible interval); 1.60 (1.38 to 1.82) vs CTRL) was the highest-ranked RTx for strength, and higher-load, multiset, twice-weekly training (0.66 (0.47 to 0.85) vs CTRL) was the highest-ranked RTx for hypertrophy. Threshold analysis demonstrated these results were extremely robust. Conclusion: All RTx promoted strength and hypertrophy compared with no exercise. The highest-ranked prescriptions for strength involved higher loads, whereas the highest-ranked prescriptions for hypertrophy included multiple sets. PROSPERO registration number: CRD42021259663 and CRD42021258902.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bjsports-2023-106807

Cites

84 of 86 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram of study selection.
Figure 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram of study selection.CC BY-NC · PubMed Central
Figure 2 Network geometry for all available studies evaluating strength (A) and hypertrophy (B). Each node represents a unique condition, and the size of each node is proportional to the sample size per condition. Each edge represents direct evidence, and the width of each edge is proportional to the number of studies comparing connected nodes. Resistance training prescriptions are denoted with a three-character acronym—XY#—where X is load (H, ≥80% 1-repetition maximum (1RM); L, <80% 1 RM); Y is sets (M, multiset; S, single-set); and # is the weekly frequency (3, ≥3 days/week; 2, 2 days/week; 1, 1 day/week), respectively. For example, ‘HM2’ denotes higher-load, multiset, twice-weekly training. CTRL, non-exercising control group.
Figure 2 Network geometry for all available studies evaluating strength (A) and hypertrophy (B). Each node represents a unique condition, and the size of each node is proportional to the sample size per condition. Each edge represents direct evidence, and the width of each edge is proportional to the number of studies comparing connected nodes. Resistance training prescriptions are denoted with a three-character acronym—XY#—where X is load (H, ≥80% 1-repetition maximum (1RM); L, <80% 1 RM); Y is sets (M, multiset; S, single-set); and # is the weekly frequency (3, ≥3 days/week; 2, 2 days/week; 1, 1 day/week), respectively. For example, ‘HM2’ denotes higher-load, multiset, twice-weekly training. CTRL, non-exercising control group.CC BY-NC · PubMed Central
Figure 3 Forest plots displaying network estimates for relative effects of resistance training prescriptions versus non-exercising control for strength (A) and hypertrophy (B). Each resistance training prescription (RTx) is denoted with a three-character acronym—XY#—where X is load (H, ≥80% 1-repetition maximum (1RM); L, <80% 1 RM); Y is sets (M, multiset; S, single-set); and # is the weekly frequency (3, ≥3 days/week; 2, 2 days/week; 1, 1 day/week), respectively. For example, ‘HM2’ denotes higher-load, multiset, twice-weekly training. CTRL, non-exercising control; SMD, standardised mean difference; 95% CrI, 95% credible interval.
Figure 3 Forest plots displaying network estimates for relative effects of resistance training prescriptions versus non-exercising control for strength (A) and hypertrophy (B). Each resistance training prescription (RTx) is denoted with a three-character acronym—XY#—where X is load (H, ≥80% 1-repetition maximum (1RM); L, <80% 1 RM); Y is sets (M, multiset; S, single-set); and # is the weekly frequency (3, ≥3 days/week; 2, 2 days/week; 1, 1 day/week), respectively. For example, ‘HM2’ denotes higher-load, multiset, twice-weekly training. CTRL, non-exercising control; SMD, standardised mean difference; 95% CrI, 95% credible interval.CC BY-NC · PubMed Central
Figure 4 Probability for each condition ranking in the top three most effective for strength (A) and hypertrophy (B). Scores closer to 100% indicate a greater chance of being ranked in the top three. Resistance training prescriptions are denoted with a three-character acronym—XY#—where X is load (H, ≥80% 1-repetition maximum (1RM); L, <80% 1 RM); Y is sets (M, multiset; S, single-set); and # is the weekly frequency (3, ≥3 days/week; 2, 2 days/week; 1, 1 day/week), respectively. For example, ‘HM2’ denotes higher-load, multiset, twice-weekly training. CTRL, non-exercising control group.
Figure 4 Probability for each condition ranking in the top three most effective for strength (A) and hypertrophy (B). Scores closer to 100% indicate a greater chance of being ranked in the top three. Resistance training prescriptions are denoted with a three-character acronym—XY#—where X is load (H, ≥80% 1-repetition maximum (1RM); L, <80% 1 RM); Y is sets (M, multiset; S, single-set); and # is the weekly frequency (3, ≥3 days/week; 2, 2 days/week; 1, 1 day/week), respectively. For example, ‘HM2’ denotes higher-load, multiset, twice-weekly training. CTRL, non-exercising control group.CC BY-NC · PubMed Central
Figure 5 Forest plots displaying network estimates for relative effects of resistance training prescriptions versus non-exercising control for mobility (A), gait speed (B) and balance/flexibility. Each resistance training prescription (RTx) is denoted with a three-character acronym—XY#—where X is load (H, ≥80% 1-repetition maximum (1RM); L, <80% 1 RM); Y is sets (M, multiset; S, single-set); and # is the weekly frequency (3, ≥3 days/week; 2, 2 days/week; 1, 1 day/week), respectively. For example, ‘HM2’ denotes higher-load, multiset, twice-weekly training. CTRL, non-exercising control; SMD, standardised mean difference; 95% CrI, 95% credible interval.
Figure 5 Forest plots displaying network estimates for relative effects of resistance training prescriptions versus non-exercising control for mobility (A), gait speed (B) and balance/flexibility. Each resistance training prescription (RTx) is denoted with a three-character acronym—XY#—where X is load (H, ≥80% 1-repetition maximum (1RM); L, <80% 1 RM); Y is sets (M, multiset; S, single-set); and # is the weekly frequency (3, ≥3 days/week; 2, 2 days/week; 1, 1 day/week), respectively. For example, ‘HM2’ denotes higher-load, multiset, twice-weekly training. CTRL, non-exercising control; SMD, standardised mean difference; 95% CrI, 95% credible interval.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 86 references

Cited by

See all 181

Metadata

Authors
Currier, B. S., Mcleod, J. C., Banfield, L., Beyene, J., Welton, N. J., D'Souza, A. C., Keogh, J. A. J., Lin, L., Coletta, G., Yang, A., Colenso-Semple, L., Lau, K. J., Verboom, A., & Phillips, S. M.
Affiliations
  • McMaster University (CA)
  • University of Bristol (GB)
Corresponding author
Phillips, Stuart M
Venue
British Journal of Sports Medicine
Publisher
BMJ
Published
2023-07-06
Volume
57
Issue
18
Pages
1211-1220
ISSN
  • 0306-3674 (ISSN-L)
  • 1473-0480
OpenAlex
W4383337711
Cited by
179
References
82
Citations by year
2026: 72 · 2025: 59 · 2024: 42 · 2023: 6
FWCI
9.89
Type
journal article
Language
en
Open access
Locations
  • British Journal of Sports Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Bristol Research (University of Bristol) (publishedVersion, cc-by-nc)
  • HighWire Press Open Archive (submittedVersion)
  • Explore Bristol Research (submittedVersion, cc-by-nc)
Funders
  • Canada Research Chairs
  • NHS Foundation Trust
  • Natural Sciences and Engineering Research Council (RGPIN-2020-06346)
  • NIHR Bristol Biomedical Research Centre
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Sports Performance and Training
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
Keywords
resistance training prescription, muscle strength, muscle hypertrophy, training load, sets, exercise frequency, healthy adults
MeSH terms
Network Meta-Analysis, Adult, Bayes Theorem, Female, Humans, Hypertrophy, Muscle, Skeletal, Muscle Strength, Resistance Training, Prescriptions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resistance training prescription for muscle strength and hypertrophy in healthy adults: a systematic review and Bayesian network meta-analysis. https://app.cochat.ai/papers/10.1136/bjsports-2023-106807
The paper
Currier, B. S., Mcleod, J. C., Banfield, L., Beyene, J., Welton, N. J., D'Souza, A. C., Keogh, J. A. J., Lin, L., Coletta, G., Yang, A., Colenso-Semple, L., Lau, K. J., Verboom, A., & Phillips, S. M. (2023). Resistance training prescription for muscle strength and hypertrophy in healthy adults: a systematic review and Bayesian network meta-analysis. British Journal of Sports Medicine. https://doi.org/10.1136/bjsports-2023-106807

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.